DENISE M. CARDO
EUA
Dr. Denise Cardo is the director of the Division of Healthcare Quality Promotion (DHQP), National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC). Dr. Cardo joined CDC in 1993 as a medical epidemiologist and, after holding several leadership positions in DHQP, she was selected as division director in 2003. Dr. Cardo leads CDC activities to prevent infections and antimicrobial resistance in healthcare settings, sepsis, and to promote healthcare safety. She has been involved in several CDC responses to emerging infection threats, including to COVID-19. In addition, she has served as CDC Acting Deputy Director for Surveillance, Epi and Lab systems (OSELS) and as CDC Acting Deputy Director for Infectious Diseases (DDID).
Prior to joining CDC, she had a distinguished career in the division of infectious diseases at one of Brazil's prestigious medical institutions, Escola Paulista de Medicina, where she received her medical degree, completed her residency and fellowship, and joined the faculty as associated professor of infectious diseases. She also did a sabbatical at the Hospital Epidemiology Program, University of Tennessee, Memphis.
Dr. Cardo has been involved in healthcare epidemiology and infection prevention for several decades and is internationally recognized as an expert and leader in the area. Her interests include patient safety, prevention of healthcare-associated infections, antimicrobial resistance, sepsis, and public health-healthcare interactions to promote health. She is the author of several research and reviewed papers including book chapters and has received several awards for her work.
EUA
Dr. Denise Cardo is the director of the Division of Healthcare Quality Promotion (DHQP), National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC). Dr. Cardo joined CDC in 1993 as a medical epidemiologist and, after holding several leadership positions in DHQP, she was selected as division director in 2003. Dr. Cardo leads CDC activities to prevent infections and antimicrobial resistance in healthcare settings, sepsis, and to promote healthcare safety. She has been involved in several CDC responses to emerging infection threats, including to COVID-19. In addition, she has served as CDC Acting Deputy Director for Surveillance, Epi and Lab systems (OSELS) and as CDC Acting Deputy Director for Infectious Diseases (DDID).
Prior to joining CDC, she had a distinguished career in the division of infectious diseases at one of Brazil's prestigious medical institutions, Escola Paulista de Medicina, where she received her medical degree, completed her residency and fellowship, and joined the faculty as associated professor of infectious diseases. She also did a sabbatical at the Hospital Epidemiology Program, University of Tennessee, Memphis.
Dr. Cardo has been involved in healthcare epidemiology and infection prevention for several decades and is internationally recognized as an expert and leader in the area. Her interests include patient safety, prevention of healthcare-associated infections, antimicrobial resistance, sepsis, and public health-healthcare interactions to promote health. She is the author of several research and reviewed papers including book chapters and has received several awards for her work.
STEPHANIE J DANCER
ESCÓCIA
Stephanie is a medical microbiologist in NHS Lanarkshire and Professor of Microbiology at Edinburgh Napier University in Scotland. She edited the Journal of Hospital Infection for over 20 years, five of them as editor-in-chief, and now edits for Infection, Disease & Health and International Journal of Antimicrobial Agents. She trained at St. Bartholomew's Hospital in London followed by postgraduate studies at Guy's Hospital, where she gained a thesis on the epidemiology and biochemistry of toxin-producing staphylococci. She has worked and travelled all over the world, including the Canadian High Arctic, where she resuscitated 30,000-year-old organisms from glacial ice. She spent six years as Infection Control Officer for Argyll before moving to Health Protection Scotland as their inaugural microbiologist (2002-5). There, she set up MRSA surveillance for Scotland, evaluated real-time PCR for MRSA screening and helped establish the Scottish Microbiology Forum. She has been a member of various working groups on antibiotic prescribing, MRSA and hospital cleaning, and is a current or recent member of NHS Scotland Decontamination; UK NICE (infection control & antimicrobial prescribing); UK HTA (screening and diagnostics); ESCMID groups on infection control, MRSA & multi-resistant Gram-negative bacilli; and 2023 ECCMID conference committee. She advised DEFRA on surface cleaning and hygiene during the COVID-19 pandemic and has been collaborating with an international group of virologists, physicists, ventilation engineers and aerosol scientists on airborne spread of SARS-CoV-2. She has published books, book chapters and over 200 papers in peer-reviewed journals on hospital cleaning, antimicrobial management, infection control and MRSA. At present, she balances editorial duties with research and teaching, specifically antimicrobial stewardship and environmental control of hospital pathogens.
ESCÓCIA
Stephanie is a medical microbiologist in NHS Lanarkshire and Professor of Microbiology at Edinburgh Napier University in Scotland. She edited the Journal of Hospital Infection for over 20 years, five of them as editor-in-chief, and now edits for Infection, Disease & Health and International Journal of Antimicrobial Agents. She trained at St. Bartholomew's Hospital in London followed by postgraduate studies at Guy's Hospital, where she gained a thesis on the epidemiology and biochemistry of toxin-producing staphylococci. She has worked and travelled all over the world, including the Canadian High Arctic, where she resuscitated 30,000-year-old organisms from glacial ice. She spent six years as Infection Control Officer for Argyll before moving to Health Protection Scotland as their inaugural microbiologist (2002-5). There, she set up MRSA surveillance for Scotland, evaluated real-time PCR for MRSA screening and helped establish the Scottish Microbiology Forum. She has been a member of various working groups on antibiotic prescribing, MRSA and hospital cleaning, and is a current or recent member of NHS Scotland Decontamination; UK NICE (infection control & antimicrobial prescribing); UK HTA (screening and diagnostics); ESCMID groups on infection control, MRSA & multi-resistant Gram-negative bacilli; and 2023 ECCMID conference committee. She advised DEFRA on surface cleaning and hygiene during the COVID-19 pandemic and has been collaborating with an international group of virologists, physicists, ventilation engineers and aerosol scientists on airborne spread of SARS-CoV-2. She has published books, book chapters and over 200 papers in peer-reviewed journals on hospital cleaning, antimicrobial management, infection control and MRSA. At present, she balances editorial duties with research and teaching, specifically antimicrobial stewardship and environmental control of hospital pathogens.